Clinical trial
Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of…
NCT00238849 · Integrated Community Oncology Network, Other · Unknown status
Key facts
| NCT number | NCT00238849 |
|---|---|
| Title | Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC. |
| Official title | Phase II Study of Oxaliplatin in Combination With Navelbine for the Second-Line Treatment of Advanced and Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | Integrated Community Oncology Network, Other |
| Collaborators | Sanofi Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Previously Treated Metastatic Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin |
| Enrollment | 40 |
| First posted | Oct 14, 2005 |
| Last update posted | Oct 14, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: